A strategy that analyzes the structural properties of RNA could help identify regions that are promising targets for antiviral drugs.

With a $50 million initial investment from Flagship, Terrana will use RNA from benign plant viruses as a chassis to carry ...

Plant RNA viruses pose a significant threat to global agriculture, affecting a vast array of crop species and leading to ...

In the vast and often unseen world of microscopic life, a recent discovery may force scientists to rethink what it means to ...

A promising path to fighting COVID and other coronaviruses may have been based on a serious mistake. Scientists had zeroed in ...

A tiny insect called a midge spreads the disease, and the earliest known case dates back to 1955 in a forest worker near a ...

With Terrana Biosciences, Moderna founder Flagship can apply its RNA knowledge to agricultural use cases like pest and ...

Because they rely on hosts for a majority of functions, viruses aren’t considered alive. But entities like ‘Sukunaarchaeum ...

The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid ...

The innate immune system is the body's first line of defense against pathogens and foreign substances. An essential component ...

A new SARS-CoV-2 variant, Nimbus or NB.1.8.1, is drawing attention due to rising transmission in parts of Asia.

Scientists have discovered Sukunaarchaeum mirabile, a unique archaeon residing within marine plankton, challenging traditional definitions of life. Th ...